OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 68 filers reported holding OVID THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,490,816 | +17.1% | 6,117,400 | 0.0% | 0.79% | +61.0% |
| Q2 2023 | $20,065,072 | +27.1% | 6,117,400 | 0.0% | 0.49% | -3.1% |
| Q1 2023 | $15,782,892 | +38.7% | 6,117,400 | 0.0% | 0.51% | +46.8% |
| Q4 2022 | $11,378,364 | +1.1% | 6,117,400 | 0.0% | 0.35% | +4.2% |
| Q3 2022 | $11,256,000 | -14.4% | 6,117,400 | 0.0% | 0.33% | -26.9% |
| Q2 2022 | $13,152,000 | -31.5% | 6,117,400 | 0.0% | 0.45% | -24.5% |
| Q1 2022 | $19,209,000 | -1.6% | 6,117,400 | +0.6% | 0.60% | -3.4% |
| Q4 2021 | $19,524,000 | -4.5% | 6,082,200 | 0.0% | 0.62% | -12.5% |
| Q3 2021 | $20,436,000 | -14.1% | 6,082,200 | 0.0% | 0.71% | -20.0% |
| Q2 2021 | $23,781,000 | -2.7% | 6,082,200 | 0.0% | 0.89% | -18.0% |
| Q1 2021 | $24,450,000 | – | 6,082,200 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 230,000 | $407,000 | 0.69% |
| BVF INC/IL | 3,293,000 | $5,829,000 | 0.65% |
| COWEN INC. | 1,101,414 | $1,950,000 | 0.21% |
| ARMISTICE CAPITAL, LLC | 1,780,000 | $3,151,000 | 0.17% |
| Granite Point Capital Management, L.P. | 417,857 | $740,000 | 0.07% |
| Redmile Group, LLC | 737,550 | $1,305,000 | 0.04% |
| Tekla Capital Management LLC | 496,977 | $880,000 | 0.04% |
| Fairpointe Capital LLC | 101,000 | $179,000 | 0.01% |
| Alyeska Investment Group, L.P. | 225,000 | $398,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,440 | $149,000 | 0.00% |